I'm LongbridgeAI, I can summarize articles.Precigen, Inc. faces governance concerns as CEO Helen Sabzevari repeatedly modifies her Rule 10b5-1 trading plan for a large stock block. While the company states the plan was pre-cleared under its Insider Trading Policy, ongoing changes to pricing and volumes may signal low insider confidence or information asymmetry to investors.
Precigen, Inc. (PGEN) has disclosed a new risk, in the Environmental / Social category.
Claim 55% Off TipRanks
- Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
- Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks
An outside observer notes that Precigen, Inc. faces perception and governance risk as its CEO, Helen Sabzevari, repeatedly modifies a Rule 10b5-1 trading plan covering a sizable block of common stock. Although the company states the plan was adopted and pre-cleared under its Insider Trading Policy, ongoing changes to pricing terms and volumes could raise investor concerns about insider confidence and potential information asymmetries.
The average PGEN stock price target is $14.50, implying 110.45% upside potential.
To learn more about Precigen, Inc.’s risk factors, click here.